Treatment of Generalised Anxiety Disorder with Venlafaxine XR: A Randomised, Double-Blind Trial in Comparison with Buspirone and Placebo

In this: publication
By this: publisher
In this Subject: Pharmacology
By this author: Rolland P.D. ;&nbsp; Kablinger A.S. ;&nbsp; Brannon G.E. ;&nbsp; Freeman A.M.

Authors: Rolland P.D.¹; Kablinger A.S.¹; Brannon G.E.¹; Freeman A.M.²

Source: Clinical Drug Investigation, Volume 19, Number 2, February 2000 , pp. 163-165(3)

Buy & download fulltext article:

Price: $62.95 plus tax (Refund Policy)

Keywords: Anxiety disorders, treatment; Anxiolytics, therapeutic use; Buspirone, therapeutic use; Serotonin uptake inhibitors, therapeutic use; Venlafaxine, therapeutic use

Language: English

Document Type: Short communication

Affiliations: 1: Psychopharmacology Research Unit, Department of Psychiatry, Louisiana State University Medical Center in Shreveport, Shreveport, Louisiana, USA 2: Department of Psychiatry, Louisiana State University Medical Center in Shreveport, Shreveport, USA *

Publication date: 2000-02-01